Glioma: Application of Histogram Analysis of Pharmacokinetic Parameters from T1-Weighted Dynamic Contrast-Enhanced MR Imaging to Tumor Grading

BACKGROUND AND PURPOSE: The usefulness of pharmacokinetic parameters for glioma grading has been reported based on the perfusion data from parts of entire-tumor volumes. However, the perfusion values may not reflect the entire-tumor characteristics. Our aim was to investigate the feasibility of glioma grading by using histogram analyses of pharmacokinetic parameters including the volume transfer constant, extravascular extracellular space volume per unit volume of tissue, and blood plasma volume per unit volume of tissue from T1-weighted dynamic contrast-enhanced perfusion MR imaging. MATERIALS AND METHODS: Twenty-eight patients (14 men, 14 women; mean age, 49.75 years; age range, 25–72 years) with histopathologically confirmed gliomas (World Health Organization grade II, n = 7; grade III, n = 8; grade IV, n = 13) were examined before surgery or biopsy with conventional MR imaging and T1-weighted dynamic contrast-enhanced perfusion MR imaging at 3T. Volume transfer constant, extravascular extracellular space volume per unit volume of tissue, and blood plasma volume per unit volume of tissue were calculated from the entire-tumor volume. Histogram analyses from these parameters were correlated with glioma grades. The parameters with the best percentile from cumulative histograms were identified by analysis of the area under the curve of the receiver operating characteristic analysis and were compared by using multivariable stepwise logistic regression analysis for distinguishing high- from low-grade gliomas. RESULTS: All parametric values increased with increasing glioma grade. There were significant differences among the 3 grades in all parameters (P < .01). For the differentiation of high- and low-grade gliomas, the highest area under the curve values were found at the 98th percentile of the volume transfer constant (area under the curve, 0.912; cutoff value, 0.277), the 90th percentile of extravascular extracellular space volume per unit volume of tissue (area under the curve, 0.939; cutoff value, 19.70), and the 84th percentile of blood plasma volume per unit volume of tissue (area under the curve, 0.769; cutoff value, 11.71). The 98th percentile volume transfer constant value was the only variable that could be used to independently differentiate high- and low-grade gliomas in multivariable stepwise logistic regression analysis. CONCLUSIONS: Histogram analysis of pharmacokinetic parameters from whole-tumor volume data can be a useful method for glioma grading. The 98th percentile value of the volume transfer constant was the most significant measure.

[1]  W P Dillon,et al.  Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. , 2000, AJNR. American journal of neuroradiology.

[2]  P. Wesseling,et al.  Angiogenesis in brain tumors; pathobiological and clinical aspects , 1997, Journal of Neuro-Oncology.

[3]  Peter Wust,et al.  Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI. , 2005, Magnetic resonance imaging.

[4]  D J Ruiter,et al.  Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. , 1994, Journal of neurosurgery.

[5]  J. Folkman,et al.  The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.

[6]  W W Hauck,et al.  A proposal for examining and reporting stepwise regressions. , 1991, Statistics in medicine.

[7]  Jue Zhang,et al.  Feasibility study of exploring a T1‐weighted dynamic contrast‐enhanced MR approach for brain perfusion imaging , 2012, Journal of magnetic resonance imaging : JMRI.

[8]  Max A. Viergever,et al.  Mutual-information-based registration of medical images: a survey , 2003, IEEE Transactions on Medical Imaging.

[9]  A. Jackson,et al.  Enhancing Fraction in Glioma and Its Relationship to the Tumoral Vascular Microenvironment: A Dynamic Contrast-Enhanced MR Imaging Study , 2010, American Journal of Neuroradiology.

[10]  Alan Jackson,et al.  A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas , 2004, Journal of magnetic resonance imaging : JMRI.

[11]  Geoff J M Parker,et al.  Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas? , 2005, AJNR. American journal of neuroradiology.

[12]  Alan Jackson,et al.  Comparative study of methods for determining vascular permeability and blood volume in human gliomas , 2004, Journal of magnetic resonance imaging : JMRI.

[13]  James M Provenzale,et al.  Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms. , 2006, AJR. American journal of roentgenology.

[14]  Seung Hong Choi,et al.  Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade. , 2011, Radiology.

[15]  Bensheng Qiu,et al.  Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas , 2012, Journal of magnetic resonance imaging : JMRI.

[16]  A. Jackson,et al.  Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors , 2000, Journal of magnetic resonance imaging : JMRI.

[17]  J. Folkman What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[18]  A. Kyritsis,et al.  Mechanisms of angiogenesis in gliomas , 2006, Journal of Neuro-Oncology.

[19]  I. Ercan,et al.  High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. , 2005, Clinical radiology.

[20]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[21]  M. Aref,et al.  Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates. , 2008, Magnetic resonance imaging.

[22]  Sanjay Behari,et al.  Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers , 2012, Neuroradiology.

[23]  A. Jackson,et al.  Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? , 2006, AJNR. American journal of neuroradiology.

[24]  Areen K. Al-Bashir,et al.  New algorithm for quantifying vascular changes in dynamic contrast‐enhanced MRI independent of absolute T1 values , 2007, Magnetic Resonance in Medicine.

[25]  M. Tate,et al.  Biology of angiogenesis and invasion in glioma , 2009, Neurotherapeutics.

[26]  D. Geng,et al.  Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging , 2012, Journal of Clinical Neuroscience.

[27]  Dinggang Shen,et al.  Robust Computation of Mutual Information Using Spatially Adaptive Meshes , 2007, MICCAI.

[28]  A. Gregory Sorensen,et al.  Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.

[29]  J C Waterton,et al.  Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast‐enhanced dynamic MR imaging , 2000, Journal of magnetic resonance imaging : JMRI.

[30]  R. Jain,et al.  Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. , 1991, Cancer research.

[31]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.